Article Details
Retrieved on: 2020-10-08 19:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Puma <b>Biotechnology</b> reports positive Neratinib Phase III data. Y-mAbs Therapeutics receives FDA rejection for omburtamab BLA. Halozyme ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here